Piramal Enterprises Ltd.

PEL

Market Cap
₹20,783 Cr.
P/E
0.00

Piramal Enterprises Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income component is making ratios of the company look optically better
Pledge
Promoters have not pledged a significant portion of their holding
Cost Of Borrowing
Cost Of Borrowing of the company seems to be trending down
Cost to Income Ratio
Operational cost of company is trending up
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Net Interest Margin
Net Interest margin of the company is trending up
Net NPA
NPA's of the company is currently under control
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a discount to 3 year historic valuations
ROE
Latest
32.1%
3yr Average
13.81%
5yr Average
9.38%
Net Profit Margin
Latest
111.58%
3yr Average
48.96%
5yr Average
31.88%
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Borrowings Break-Up

locked
Source
|
Latest
|
locked
Historic

Borrowing Break-Up - Investor Type

locked
Source
|
Latest
|
locked
Historic

AUM Break-Up - NBFC

locked
Source
|
Latest
|
locked
Historic

Verticals -Wholesale

locked
Source
|
Latest
|
locked
Historic

Verticals -Retail

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    Peer Comparison
    Brands
    Lacto Calamine
    Saridon
    i-pill
    Suppliers
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Piramal Enterprises Ltd.
    One Upcoming Special Situation Opportunity - SOIC
    View the discussion on ValuePickr
    Piramal Enterprises and upcoming special situation - The Average Trader
    Special Situation - Demerger Of Piraml Enterprise & Piramal Pharma - SOIC
    Transformation of Piramal group post 2018 NBFC crisis - Business Today
    NBFC
    Buy Now Pay Later - Capital Mind
    Deep Dive into NBFC Business - Omkara Capital
    Asset Liability Mismatch: Why do NBFCs & Banks knowingly create it? - Dr Vijay Malik
    NBFC & Banks| How to find Multibaggers in this sector! - SOIC
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline